Traci Blonquist

Traci Blonquist

Auto-generated profile, based on publicly available information

Traci Blonquist

Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 June 2015 in Journal of Medical Internet Research
Verified
Journal Article
Open access
DBDonna Berry
Donna Berry
TBTraci M Blonquist
Traci M Blonquist
RPRupa A Patel
Rupa A Patel
BHBarbara Halpenny
Barbara Halpenny
JMJustin McReynolds
Justin McReynolds
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet

16 June 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
Oliver ChenOliver Chen
Oliver Chen
TBTraci M. Blonquist
Traci M. Blonquist
EMEunice Mah
Eunice Mah
KSKristen Sanoshy
Kristen Sanoshy
DBDawn Beckman
Dawn Beckman
BSBrianna Stubbs
Brianna Stubbs
Nutritional ketosis is a state of mildly elevated blood ketone concentrations resulting from dietary changes (e.g., fasting or reduced carbohydrate intake) or exogenous ketone consumption. In this study, we determined the tolerability and safety of a novel exogenous ketone diester, bis-hexanoyl-(R)-1,3-butanediol (BH-BD), in a 28-day, randomized, double-blind, placebo-controlled, parallel trial (NCT04707989). Healthy adults (n = 59, mean (SD), age: 42.8 (13.4) y, body mass index: 27.8 (3.9) kg/m2) were randomized to consume a beverage containing 12.5 g (Days 0–7) and 25 g (Days 7–28) of BH-BD or a taste-matched placebo daily with breakfast. Tolerability, stimulation, and sedation were assessed daily by standardized questionnaires, and blood and urine samples were collected at Days 0, 7, 14, and 28 for safety assessment. There were no differences in at-home composite systemic and gastrointestinal tolerability scores between BH-BD and placebo at any time in the study, or in acute tolerability measured 1-h post-consumption in-clinic. Weekly at-home composite tolerability scores did not change when BH-BD servings were doubled. At-home scores for stimulation and sedation did not differ between groups. BH-BD significantly increased blood ketone concentrations 1-h post-consumption. No clinically meaningful changes in safety measures including vital signs and clinical laboratory measurements were detected within or between groups. These results support the overall tolerability and safety of consumption of up to 25 g/day BH-BD.

5 March 2018 in Blood Advances
Verified
Journal Article
Closed access
TTThai Hoa Tran
Thai Hoa Tran
MHMarian H. Harris
Marian H. Harris
JNJonathan V. Nguyen
Jonathan V. Nguyen
TBTraci M. Blonquist
Traci M. Blonquist
KSKristen E. Stevenson
Kristen E. Stevenson
LSLewis B. Silverman
Lewis B. Silverman
Key Points: Fifteen percent of NCI high-risk, Ph-negative, B-ALL patients harbored a kinase-activating fusion, and often associated with IKZF1 deletion. IKZF1 deletion represents an independent prognostic factor of poor outcomes, regardless of fusion-positivity.

20 October 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
Jagmeet MadanJagmeet Madan
Jagmeet Madan
TBTraci Blonquist
Traci Blonquist
EREram Rao
Eram Rao
AMAnkita Marwaha
Ankita Marwaha
JMJoshya Mehra
Joshya Mehra
Oliver ChenOliver Chen
Oliver Chen
Home confinement during the COVID-19 pandemic is accompanied by dramatic changes in lifestyle and dietary behaviors that can significantly influence health. We conducted an online cross-sectional survey to assess COVID-19 pandemic-induced dietary and lifestyle changes and their association with perceived health status and self-reported body weight changes among 1000 Indian adults in early 2021. Positive improvements in dietary habits, e.g., eating more nutritious (85% of participants) and home-cooked food (89%) and an increase in overall nutrition intake (79%), were observed. Sixty-five percent of participants self-reported increased oat consumption to support immunity. There were some negative changes, e.g., more binge eating (69%), eating more in between meals (67%), and increasing meal portion size (72%). Two-thirds of participants reported no change in lifestyles, whereas 21 and 23% reported an increase, and 13 and 10% reported a decrease in physical activity and sleep, respectively. Overall, 64 and 65% of participants reported an improvement in perceived health and an increase in body weight during the COVID-19 period compared to pre-COVID-19, respectively. The top motivations for improving dietary habits included improving physical and mental health and building immunity. In conclusion, the overall perceived health was improved and there was an increase in self-reported body weight in most participants during COVID-19. Diet emerged as the most crucial determinant for these changes.

25 June 2018 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
MMMarc R. Mansour
Marc R. Mansour
SHShuning He
Shuning He
ZLZhaodong Li
Zhaodong Li
RLRiadh Lobbardi
Riadh Lobbardi
BABrian J. Abraham
Brian J. Abraham
ALA. Thomas Look
A. Thomas Look
A substantial subset of patients with T cell acute lymphoblastic leukemia (T-ALL) develops resistance to steroids and succumbs to their disease. JDP2 encodes a bZIP protein that has been implicated as a T-ALL oncogene from insertional mutagenesis studies in mice, but its role in human T-ALL pathogenesis has remained obscure. Here we show that JDP2 is aberrantly expressed in a subset of T-ALL patients and is associated with poor survival. JDP2 is required for T-ALL cell survival, as its depletion by short hairpin RNA knockdown leads to apoptosis. Mechanistically, JDP2 regulates prosurvival signaling through direct transcriptional regulation of MCL1. Furthermore, JDP2 is one of few oncogenes capable of initiating T-ALL in transgenic zebrafish. Notably, thymocytes from rag2:jdp2 transgenic zebrafish express high levels of mcl1 and demonstrate resistance to steroids in vivo. These studies establish JDP2 as a novel oncogene in high-risk T-ALL and implicate overexpression of MCL1 as a mechanism of steroid resistance in JDP2-overexpressing cells.

1 October 2021 in Nutrition
Verified
Journal Article
Open access
OCOliver Chen
Oliver Chen
SSSailendharan Sudakaran
Sailendharan Sudakaran
TBTraci Blonquist
Traci Blonquist
EMEunice Mah
Eunice Mah
SDShane Durkee
Shane Durkee
ABAouatef Bellamine
Aouatef Bellamine
Promising evidence suggests beneficial health effects of arabinogalactan, but little is known about the effect of this non-digestible carbohydrate on the gut microbiota, a crucial mediator of human health. The objective of this study was to investigate the effect of an arabinogalactan product (ResistAid) on the fecal microbiome and short-chain fatty acids and gastrointestinal tolerance in healthy adults in a randomized, double-blind, crossover trial. Thirty adults were randomly assigned to consume 15 g/d maltodextrin (control) or ResistAid for 6 wk. At week 6, compared to placebo, ResistAid supplementation led to a significant decrease in the ratio of fecal Firmicutes to Bacteroidetes, driven by an increase in Bacteroidetes and a decrease in Firmicutes. Moreover, the relative abundance of Bifidobacterium tended to increase with ResistAid supplementation. Additionally, ResistAid significantly decreased the α-diversity of the fecal microbiome. Predicted functional abundances based on 16S rRNA sequences showed that ResistAid supplementation increased the gene abundance of the gut microbiome for α-l-rhamnosidase, β-fructosidase, and levanase, as well as tricarboxylic acid and vitamin B6 biosynthesis pathways. Fecal isovaleric, valeric, and hexanoic acids were significantly lower after ResistAid consumption. There were no statistically significant changes in bowel habit, stool consistency, gastrointestinal tolerance symptoms, chemistry profile, metabolic panel, or vitals, suggesting that consumption of 15 g daily ResistAid over 6 wk is safe. These results demonstrate that the gut microbiome composition and predicted functions can be modulated by ResistAid consumption, perhaps suggesting a mechanistic explanation on its reported benefits in metabolic parameters and the immune system.